Entities / Company
Sophia Genetics.
Health technology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
Sophia Genetics shares are currently being traded on the Nasdaq exchange.Some support1 report
-
Bioz partnered with Sophia Genetics on July 15, 2025, to provide custom integration and transparency.Some support1 report
-
Sophia Genetics announced company results on July 22, 2025, leveraging its presence in Boston and Switzerland, and utilizing the LinkedIn platform.Some support1 report
-
Sophia Genetics announced a multi-year AI breast cancer partnership with AstraZeneca, leveraging its technology for biopharma applications.Some support1 report
-
Sophia Genetics and AZ Delta collaborate to bring genomic testing to cancer patients, utilizing AZ Delta's operations in Hasselt, Belgium.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Sophia Genetics this week
News at the entities that move Sophia Genetics most-
AstraZeneca OperationalAstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Moves Sophia Genetics
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Sophia Genetics
Connections
The 4 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Sophia Genetics shares are listed and traded on the Nasdaq stock exchange.
-
AZ Delta Structural
Sophia Genetics supplies sequencers and its technology is adopted by AZ Delta for pathology operations.
-
Jurgi Camblong Structural
Jurgi Camblong serves as the CEO and Co-founder of Sophia Genetics.
-
AstraZeneca Operational
AstraZeneca and Sophia Genetics have formed a multi-year partnership to leverage AI for breast cancer therapies.
History
Events by the month they beganJune 2026
6 events- Tempus AI is part of the Tempus group, and Sophia Genetics partners with AstraZeneca while Tempus collaborates with Boehringer Ingelheim on cancer therapies.
- Sophia Genetics shares are currently being traded on the Nasdaq exchange.
- Bioz partnered with Sophia Genetics on July 15, 2025, to provide custom integration and transparency.
- Sophia Genetics announced company results on July 22, 2025, leveraging its presence in Boston and Switzerland, and utilizing the LinkedIn platform.
- Sophia Genetics announced a multi-year AI breast cancer partnership with AstraZeneca, leveraging its technology for biopharma applications.
- Sophia Genetics and AZ Delta collaborate to bring genomic testing to cancer patients, utilizing AZ Delta's operations in Hasselt, Belgium.